Rosa Manetta
Division of Radiology, S. Salvatore Hospital, L’Aquila, Italy
Ilaria Capretti
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Noemi Belleggia
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Claudia Marsecano
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Angelo Viscido
Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, L’Aquila, Italy
Federico Bruno
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Francesco Arrigoni
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Liheng Ma
Department of Radiology, GuangDong Pharmaceutical University, Guangzhou, Cina
Giuseppe Guglielmi
Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Foggia, Italy
Alessandra Splendiani
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Ernesto Di Cesare
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Carlo Masciocchi
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Antonio Barile
Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Keywords
MR Enterography, Crohn’s disease, IBD, CEUS
Abstract
Crohn’s disease (CD) is a chronic idiopathic disease and its diagnosis is based on a combination of clinical symptoms, laboratory tests and imaging data. There isn’t a diagnostic gold standard: the ileocolonoscopy with mucosal biopsies represents the standard for luminal disease, while cross-sectional imaging such as Ultrasound (US), Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) can show transmural alterations and extraintestinal manifestations. CD is usually diagnosed in the young age and after baseline diagnosis, the patients have to undergo to variable follow-up depending on remission or active disease. The aim of our review is to compare Magnetic Resonance Enterography (MRE) to Ultrasonography (US) in the follow-up of CD.
Abstract